Jim Cramer on Hims & Hers Health stock: 'I bet the business stays strong'

CNBC's Jim Cramer gave his take on the Hims & Hers Health, a digital health and wellness platform, saying it might be worth opening a position in the stock now that it's pulled back somewhat from its highs.

"I'd never recommend paying up for HIMS after that big run to $25, but now that it's pulled back to $20, I think you can justify building a position here, especially if you buy it gradually on the way down and don't place all your hopes on the temporary GLP-1 business, even as it is incredibly strong," he said.

The company is allowed to sell these copycat drugs because there is a significant shortage of the medication. Cramer pointed out that even though this particular revenue stream is temporary, it may be a while before GLP-1 supply catches up with the demand. Hims & Hers said it eventually plans to give customers access to the branded drugs — currently produced by pharmaceutical giants

日本 最新ニュース, 日本 見出し

Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。

Jim Cramer's top 10 things to watch in the stock market MondayWall Street was looking higher early Monday after finishing higher for the holiday-shortened trading week
ソース: CNBC - 🏆 12. / 72 続きを読む »

Jim Cramer's top 10 things to watch in the stock market TuesdayWall Street pushed higher after more records for the S&P 500 and Nasdaq.
ソース: CNBC - 🏆 12. / 72 続きを読む »

Jim Cramer's top 10 things to watch in the stock market WednesdayWall Street is getting ready for Day 2 of Federal Reserve Chairman Jerome Powell on Capitol Hill.
ソース: CNBC - 🏆 12. / 72 続きを読む »

Jim Cramer's top 10 things to watch in the stock market TuesdayWall Street was under some pressure ahead of the open after the S&P 500 and the Nasdaq started the new week with more records.
ソース: CNBC - 🏆 12. / 72 続きを読む »